1-13 of 13
Section: Genitourinary Cancer: Prostate
Sort by
Journal Article
Perspectives on Treatment of Metastatic Castration‐Resistant Prostate Cancer
Axel S. Merseburger and others
The Oncologist, Volume 18, Issue 5, May 2013, Pages 558–567, https://doi.org/10.1634/theoncologist.2012-0478
Published: 10 May 2013
Journal Article
Unmet Needs in the Prediction and Detection of Metastases in Prostate Cancer
Oliver Sartor and others
The Oncologist, Volume 18, Issue 5, May 2013, Pages 549–557, https://doi.org/10.1634/theoncologist.2013-0027
Published: 06 May 2013
Journal Article
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration‐Resistant Prostate Cancer
Emmanuel S. Antonarakis and others
The Oncologist, Volume 18, Issue 2, February 2013, Pages 163–173, https://doi.org/10.1634/theoncologist.2012-314
Published: 22 January 2013
Journal Article
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
Daniel Keizman and others
The Oncologist, Volume 17, Issue 12, December 2012, Pages 1508–1514, https://doi.org/10.1634/theoncologist.2012-0125
Published: 12 September 2012
Journal Article
Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review
Mridul Datta and Gary G. Schwartz
The Oncologist, Volume 17, Issue 9, September 2012, Pages 1171–1179, https://doi.org/10.1634/theoncologist.2012-0051
Published: 25 July 2012
Journal Article
Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?
Samuel J. Klempner and Glenn Bubley
The Oncologist, Volume 17, Issue 6, June 2012, Pages 830–837, https://doi.org/10.1634/theoncologist.2012-0094
Published: 22 May 2012
Journal Article
Changes in Biomarkers of Inflammation and Angiogenesis During Androgen Deprivation Therapy for Prostate Cancer
Philip J. Saylor and others
The Oncologist, Volume 17, Issue 2, February 2012, Pages 212–219, https://doi.org/10.1634/theoncologist.2011-0321
Published: 02 February 2012
Journal Article
Novel Therapeutic Strategies for Metastatic Prostate Cancer in the Post‐Docetaxel Setting
Oliver Sartor and others
The Oncologist, Volume 16, Issue 11, November 2011, Pages 1487–1497, https://doi.org/10.1634/theoncologist.2010-0412
Published: 02 November 2011
Journal Article
The Epothilones: New Therapeutic Agents for Castration‐Resistant Prostate Cancer
Tanya B. Dorff and Mitchell E. Gross
The Oncologist, Volume 16, Issue 10, October 2011, Pages 1349–1358, https://doi.org/10.1634/theoncologist.2010-0014
Published: 30 September 2011
Journal Article
Castration‐Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment
Rahul Aggarwal and Charles J. Ryan
The Oncologist, Volume 16, Issue 3, March 2011, Pages 264–275, https://doi.org/10.1634/theoncologist.2010-0216
Published: 21 February 2011
Journal Article
The Role of RANK‐Ligand Inhibition in Cancer: The Story of Denosumab
Daniel Castellano and others
The Oncologist, Volume 16, Issue 2, February 2011, Pages 136–145, https://doi.org/10.1634/theoncologist.2010-0154
Published: 01 February 2011
Journal Article
What Do Prostate Cancer Patients Die Of?
Matias Riihimäki and others
The Oncologist, Volume 16, Issue 2, February 2011, Pages 175–181, https://doi.org/10.1634/theoncologist.2010-0338
Published: 21 January 2011
Journal Article
Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
Ravi A. Madan and others
The Oncologist, Volume 15, Issue 9, September 2010, Pages 969–975, https://doi.org/10.1634/theoncologist.2010-0129
Published: 26 August 2010
Advertisement
Advertisement